Expression was observed predominantly by CD4+ T cells compared to CD8+ T cells in both BPH tissue and PBMCs (29.5% CD4+/CD25+vs. 2.4% CD8+/CD25+ in BPH tissue) (Figure 1 and Table 3). This evidence concerns the gene CD8A and benign prostatic hyperplasia.